Vioxx's history and the need for better procedures and better testing.
Gilhooley
Margaret
M
Seton Hall Law School, USA.
D016907:Adverse Drug Reaction Reporting Systems; D001168:Arthritis / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002986:Clinical Trials as Topic / Q000266:history; D003257:Consumer Product Safety; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects / Q000266:history; D017277:Drug Approval; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry / Q000331:legislation & jurisprudence; D004348:Drug Labeling / Q000266:history / Q000331:legislation & jurisprudence; D033161:Government Regulation / Q000266:history; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007783:Lactones / Q000009:adverse effects / Q000266:history; D011358:Product Surveillance, Postmarketing; D013450:Sulfones / Q000009:adverse effects / Q000266:history; D014481:United States; D014486:United States Food and Drug Administration
D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D013450:Sulfones